mercia pharmaceuticalsMercia Pharma - developer and manufacturer of immunotherapeutic products site map
"Developer and manufacturer of safe, effective and affordable immunotherapeutic products for the prevention
and treatment of chronic diseases."
you are here: about mercia pharma > contract manufacture
   
About Mercia Pharma  
   
Contract Manufacture  
Adjuvant Systems  
Immunotherapeutic Products  
   
Organization & Management  
   
Strategic Alliances  
   
Contact Mercia Pharma  

contract manufacturing
conjugation

Contract manufacture

Through its exclusive relationship with Nova Laboratories Ltd., Mercia Pharma provides access to a dedicated, fully compliant GMP facility in Wigston, UK. We have expertise in GMP-compliant, aseptic manufacture of pyrogen-free immunotherapeutics including therapeutic vaccines and component products. We get involved in our customer’s projects and work with them to understand their specific needs, and tailor specialist services to match the project as it evolves.

Specialities

  Therapeutic vaccines.
  Conjugated protein and peptide-based antigens.
  Adjuvant systems.
  Immunogenic formulations.

Facilities and expertise

  Fully validated, regulatory approved 2000 m2 manufacturing facility, including multiple clean rooms and isolators (class 100/class A and B); preparation areas (class 10,000 /class C); storage areas (class 100,000/classD).
  State of the art containment technology using multiple 4 to 14 glove gassed-isolators and technology for containment and aseptic handling of complex, apyrogenic, pharmaceutical formulations.
 


Analytical testing, including:

  Chemical: HPLC, GC, Karl Fisher, SDS/IEF PAGE, ELISA, IR, UV/VIS spectrophotometry, amino acid analysis, mass spec.
  Physical: Laser particle sizing and particle size distribution, viscosity, density, conductivity, video microscopy.
  Microbiological: Sterility, microbial burden, endotoxin.
  Immunological: Immunogenicity and immunopotency testing.

Services

  GMP-compliant, aseptic, manufacture from development through clinical testing to full commercial scale.
  Formulation process and regulatory expertise can be provided where required to support product development, process optimization, scale up, validation and commercial manufacture.
  Analytical testing, methods transfer, development and validation for in-process and release testing of products are available on site in GMP-compliant facilities.
  Stability testing of products and components can be undertaken.
  Clinical Trials Supply Chain Management can be provided, including: product storage, labelling, randomization, distribution and reconciliation.
  Qualified Persons on staff for release of clinical trials and commercial supplies for use in Europe.

Manufacturing Licenses and Experience

  Nova Laboratories, Ltd., Wigston, U.K. GMP Facility
  Full (MHRA, UK) Manufacturer’s License for commercial supplies.
  Investigational Medicinal Products License (IMP) (European Clinical Trials Directive 2001/20/EC).
  ISO9001: 2000 registration.
  ISO13485:2003 registration.

home | contract manufacture | adjuvant systems | immunotherapeutic products | organization & management | alliances | contact us
©copyright mercia pharma 2005 | terms of use | site design: ibrow media.com